27 results
DEFR14A
ARCT
Arcturus Therapeutics Holdings Inc
12 May 22
Revised proxy
5:00pm
to the public health impact of the coronavirus outbreak and to support the health and well-being of our employees, stockholders, and our community, the Annual
8-K
EX-14.1
3jbjys0xvc2awayvp wm
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
424B5
w91arb
8 Dec 20
Prospectus supplement for primary offering
5:30pm
424B5
hmmsmmg v0n
7 Dec 20
Prospectus supplement for primary offering
5:20pm
PRE 14A
yjwzg2
2 Oct 20
Preliminary proxy
4:20pm
S-8
EX-4.3
36zh06s38sbybk2i6rj
5 Aug 20
Registration of securities for employees
12:00am
424B5
xz41zk 5ft
30 Jul 20
Prospectus supplement for primary offering
6:01am
424B5
okejqa0fzz9s552
28 Jul 20
Prospectus supplement for primary offering
4:17pm